Legal & Ethical FAQ

No. A scheduling description does not, by itself, establish medical approval, authorization for a specific use, or compliance with every applicable health requirement. The botanical source often associated with ibogaine is Tabernanthe iboga; botanical identity does not answer product, facility, advertising, or professional-practice questions.

Ask for the exact legal basis being cited and consult official COFEPRIS materials or a licensed Mexican attorney for definitive interpretation.

It may be relevant evidence about a named product, establishment, professional, or process. It should not be treated as a blanket assurance that all services are authorized, that all claims are accurate, or that any particular outcome is assured.

Request the document itself, confirm the issuing authority and scope, and compare the named entity with the entity presenting the service. The detailed regulatory review framework is designed to keep those questions distinct.

Liability depends on specific facts, agreements, professional roles, location, applicable law, and available remedies. A waiver, contract, or broad disclaimer should not be assumed to resolve those issues. Ask which individuals or entities hold responsibility for decisions, records, emergency coordination, and follow-up.

For a definitive view, consult an attorney licensed to advise on the relevant Mexican law and the laws that may apply to a foreign patient’s circumstances.

Be cautious with language that promises outcomes, minimizes material risk, suggests universal suitability, or presents testimonials as a substitute for verifiable information. Ethical communication should make meaningful limits visible and avoid turning uncertainty into certainty.

For medical-risk questions, use the medical safety primer as a question guide, then discuss individual circumstances with appropriately qualified health professionals.

Questions about Tabernanthe iboga sourcing should include traceability, cultivation or harvest practices, supplier accountability, benefit-sharing, and respect for the communities and traditions connected to the plant. These are ethical questions even where a seller describes a supply chain as legal.

The Convention on Biological Diversity’s access and benefit-sharing information provides useful context for why genetic resources and traditional knowledge can carry responsibilities beyond a purchase transaction.

Before sharing sensitive information, ask who controls the record, how consent is documented, where data are stored, how long records are retained, and how a copy can be obtained. Also ask how information would be transferred, with permission, to a clinician at home if continuity is needed.

Mexico’s federal data-protection authority, INAI, is a useful official reference point for personal-data rights and governance. Cross-border circumstances can add complexity, so legal advice may be appropriate.

Ask for verifiable identifying details rather than a verbal assurance: the issuing authority, document number where appropriate, current date, covered activity, responsible entity, and direct method for confirmation. For professional credentials, ask how professional authorization can be verified through the relevant official process.

For emergency planning, ask whether an agreement exists, what it covers, whether it is current, which receiving facility is named, and how transfer responsibility is assigned. Do not assume a reference to a hospital or ambulance proves a current transfer arrangement.